Epidemiology References

Definition of COPD 

  1. Global initiative for chronic Obstructive Lung Disease (GOLD 2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://goldcopd.org/.
  2. Kumar P, Clark M. Respiratory disease. Clinical Medicine Sixth Edition. 2005.
  3. Barnes PJ. Mechanisms in COPD: differences from asthma. Chest 2000;117: 10S–14S.
  4. O'Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2014;15: 61–67.
  5. Marieb EN. Human Anatomy and Physiology CA: Benjamin-Cummings Publishing. 1995.

Prevalence, Age and Gender and Burden 

  1. World Health Organization. Facts sheet No.310, updated May 2014. Last accessed 7 October 2016. http://www.who.int/mediacentre/factsheets/fs310/en/.
  2. World Health Organization. Health statistics and information systems: Estimates for 2000–2012. Last accessed 7 October 2016. http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html
  3. Joish VN, Brady E, Stockdale W, et al. Evaluating Diagnosis and Treatment Patterns of COPD in Primary Care. Treat Respir Med 2006;5:283–293.
  4. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009;374:721–732.
  5. Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010;104:550–556.
  6. Jones RC, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014;2:267–276.
  7. Sundblad BM, Larsson K, Nathell L. Low awareness of COPD among physicians. Clin Respir J 2008;2:11–16.
  8. Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012;7:457–494.
  9. Gibson GJ, Loddenkemper R, Sibille Y, Lundbäck B, eds. European Lung White Book. Chronic obstructive pulmonary disease. Last accessed 10 October 2016. http://www.erswhitebook.org/files/public/Chapters/13_COPD.pdf.
  10. European COPD Coalition. Prevalence in EU. Last accessed 10 October 2016. http://www.copdcoalition.eu/about-copd/prevalence.
  11. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease study 2010. Lancet 2012;380:2163–2196.
  12. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015;5:020415.
  13. Ciapponi A, Alison L, Agustina M, et al. The epidemiology and burden of COPD in Latin America and the Caribbean: systematic review and meta-analysis. COPD 2014;11:339–350.
  14. Bao H, Fang L, Wang L. [Prevalence of chronic obstructive pulmonary disease among community population aged ≥40 in China: a meta-analysis on studies published between 1990 and 2014]. Zhonghua Liu Xing Bing Xue Za Zhi 2016;37:119–124.
  15. Landis SH, Muellerova H, Mannino DM, et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis 2014;9:597–611.
  16. Bousquet J, Khaltaev N (eds). Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. World Health Organization. 2007. Last accessed 11 October 2016. http://www.who.int/respiratory/publications/global_surveillance/en/.
  17. Hernandez P, Balter M, Bourbeau J, et al. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med 2009;103:1004–1012.
  18. Taking Her Breath Away: The Rise of COPD in Women. American Lung Association. 2013. Last accessed 11 October 2016. http://www.lung.org/our-initiatives/research/lung-health-disparities/the-rise-of-copd-in-women.html.
  19. O'Farrell A, De La Harpe D, Johnson H, et al. Trends in COPD mortality and in-patient admissions in men & women: evidence of convergence. Ir Med J 2011;104:245–248.
  20. Bischoff EW, Schermer TR, Bor H, et al. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract 2009;59:927–933.
  21. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002;47:1184–1199.
  22. World Health Organization. Health statistics and information systems: Estimates for 2000–2012. Last accessed 11 October 2016. http://www.who.int/healthinfo/global_burden_disease/estimates/en/index2.html.
  23. World Health Organization. Health statistics and information systems: Projections of mortality and burden of disease, 2004-2030. Last accessed 11 October 2016. http://www.who.int/healthinfo/global_burden_disease/DALY6_2030.xls?ua=1.
  24. Guarascio AJ, Ray SM, Finch CK, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013;5:235–245.
  25. Gibson GJ, Loddenkemper R, Sibille Y, Lundbäck B, eds. European Lung White Book. The economic burden of lung disease. Last accessed 11 October 2016. http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/
  26. European Lung Foundation. COPD - Burden in Europe. 2011.